A. Méjean

593 total citations
28 papers, 338 citations indexed

About

A. Méjean is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, A. Méjean has authored 28 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in A. Méjean's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (10 papers) and Renal and Vascular Pathologies (5 papers). A. Méjean is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (10 papers) and Renal and Vascular Pathologies (5 papers). A. Méjean collaborates with scholars based in France, Belgium and Italy. A. Méjean's co-authors include Thierry Lebrét, Nicolas Thiounn, Marc‐Olivier Timsit, Marie‐France Mamzer, François Paraf, S. Merran, O. Hélénon, Patrick Lévy, F. Cornud and Philippe Arjane and has published in prestigious journals such as Nephrology Dialysis Transplantation, Acta Oncologica and European Journal of Surgical Oncology.

In The Last Decade

A. Méjean

26 papers receiving 332 citations

Peers

A. Méjean

PRM

SURGE

TRANS

Natalie Naiman United States

Montserrat Díaz Spain

Caroline Maloney United States

N. Bissada United States

Akihiko Aoki Japan

Dorota Broniszczak Poland

Edward Schervish United States

Ángeles Montero United Kingdom

Ana Garrido Spain

Alexander A. Dekovich United States

Natalie Naiman United States

A. Méjean

138 ×0.5

PRM

251 ×1.8

41 ×0.5

SURGE

38 ×0.8

TRANS

28 ×0.7

Citations per year, relative to A. Méjean A. Méjean (= 1×) peers Natalie Naiman

Countries citing papers authored by A. Méjean

Since Specialization

Citations

This map shows the geographic impact of A. Méjean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Méjean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Méjean more than expected).

Fields of papers citing papers by A. Méjean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Méjean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Méjean. The network helps show where A. Méjean may publish in the future.

Co-authorship network of co-authors of A. Méjean

This figure shows the co-authorship network connecting the top 25 collaborators of A. Méjean. A scholar is included among the top collaborators of A. Méjean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Méjean. A. Méjean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Savoie, P.-H., N. Morel-Journel, T. Murez, et al.. (2020). Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : tumeurs malignes du pénis. Progrès en Urologie. 30(12). S252–S279. 4 indexed citations

Corréas, Jean-Michel, A. Masson-Lecomte, Stéphane Sanchez, et al.. (2017). Comparaison des résultats opératoires et oncologiques de la néphrectomie partielle et de l’ablation par radiofréquence pour traitement des tumeurs rénales chez les patients de plus de 75 ans. Progrès en Urologie. 28(1). 55–61. 2 indexed citations

Beauval, Jean‐Baptiste, Guillaume Ploussard, Bastien Cabarrou, et al.. (2016). Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World Journal of Urology. 35(8). 1191–1197. 10 indexed citations

Sèbe, Philippe, L. Ferretti, P.-H. Savoie, et al.. (2016). Recommandations en onco-urologie 2016-2018 du CCAFU : Tumeurs malignes du pénis. Progrès en Urologie. 27. S167–S179. 6 indexed citations

Timsit, Marc‐Olivier, Xin Yuan, Bernhard Floerchinger, et al.. (2010). Une technique institutionnelle de transplantation rénale chez le rat. Progrès en Urologie. 21(3). 173–176. 3 indexed citations

Henry, Nathalie, et al.. (2010). Particularités pronostiques, histopathologiques, génétiques et thérapeutiques du carcinome à cellules rénales tubulopapillaire. Progrès en Urologie. 20(6). 393–401. 2 indexed citations

Audenet, François, Morgan Rouprêt, & A. Méjean. (2009). Cancer du rein et thérapies ciblées : controverses sur les prises en charge thérapeutiques. Progrès en Urologie. 19(9). 596–605. 3 indexed citations

Timsit, Marc‐Olivier, Thierry Lebrét, Laurent Yonneau, et al.. (2009). Impact de l’indication impérative sur la morbidité et les résultats carcinologiques à long terme après néphrectomie partielle. Progrès en Urologie. 19(7). 481–486. 5 indexed citations

Lebrét, Thierry & A. Méjean. (2008). Gestion des effets secondaires de la suppression androgénique. Progrès en Urologie. 18. S338–S342. 1 indexed citations

10.

Neuzillet, Y., A. Méjean, & Thierry Lebrét. (2008). Sites métastatiques atypiques du cancer du pénis. Progrès en Urologie. 18. S396–S398. 1 indexed citations

11.

Lebrét, Thierry, Mario Di Palma, Joana Ripoll, & A. Méjean. (2008). Les soins de support pour les patients souffrant d’un cancer urologique métastasé. Progrès en Urologie. 18. S410–S414.

12.

Canaud, Guillaume, M.O. Timsit, Julien Zuber, et al.. (2008). Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy. Nephrology Dialysis Transplantation. 24(4). 1325–1327. 21 indexed citations

13.

Timsit, Marc‐Olivier, Thierry Lebrét, & A. Méjean. (2008). Chimiothérapies du cancer de prostate métastatique hormonoréfractaire ou hormonorésistant. Progrès en Urologie. 18. S365–S375. 8 indexed citations

14.

Lebrét, Thierry & A. Méjean. (2008). Place de l’hormonothérapie dans le traitement du cancer de prostate métastatique. Progrès en Urologie. 18. S332–S337. 2 indexed citations

15.

Timsit, M.O., Nicolas Barry Delongchamps, Michaël Peyromaure, et al.. (2008). Néphrectomie partielle laparoscopique : courbe d’apprentissage d’un interne en urologie sur un modèle porcin. Progrès en Urologie. 18(6). 344–350. 5 indexed citations

16.

Zini, Luca, J.-J. Patard, Umberto Capitanio, et al.. (2008). The use of partial nephrectomy in European tertiary care centers. European Journal of Surgical Oncology. 35(6). 636–642. 61 indexed citations

17.

Cohen, David, Marc‐Olivier Timsit, Yves Chrétien, et al.. (2008). Place de la néphrectomie chez les patients atteints de polykystose rénale autosomique dominante de l’adulte en attente de transplantation rénale. Progrès en Urologie. 18(10). 642–649. 23 indexed citations

18.

Lebrét, Thierry & A. Méjean. (2008). Les métastases des cancers urologiques : historique, définitions et enjeux. Progrès en Urologie. 18. S143–S146. 1 indexed citations

19.

Méjean, A. & Thierry Lebrét. (2008). Gestion des toxicités des traitements cibles dans le traitement du cancer du rein métastatique. Progrès en Urologie. 18. S315–S319. 1 indexed citations

20.

Pagnoux, Christian, et al.. (1997). Pyélonéphrite emphysémateuse chez le diabétique. La Revue de Médecine Interne. 18(11). 888–892. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact